menu
    • menu

    Company profile for Kiora Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publically traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.Kiora’s pipeline has recently expanded from one to three clinical stage candidates (with multiple possible indications). Stay tuned as the ne...
    Kiora Pharmaceuticals, Inc. (Kiora) is an ophthalmic specialty pharmaceutical company that develops therapies for the treatment of different types of eye diseases. Publically traded on the NASDAQ under KPRX, our mission is to help patients improve their ocular health and restore vision.Kiora’s pipeline has recently expanded from one to three clinical stage candidates (with multiple possible indications). Stay tuned as the new management team advances these assets with key clinical milestones in the upcoming 12 to 18 months.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kiora PharmaceuticalsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1371 East 2100 South Suite 200 Salt Lake City, UT 84105
    Telephone
    Telephone
    1-781-788-8869
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kiorapharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiora Pharma Joins Rare-X Vision Consortium to Develop Treatment
    Kiora Pharma Joins Rare-X Vision Consortium to Develop Treatment

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kiora-pharmaceuticals-joins-rare-x-vision-consortium-promoting-collaboration-and-development-of-new-treatments-for-rare-ocular-disorders-302599561.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share
    Cash-strapped eye disease biotech halves portfolio
    Cash-strapped eye disease biotech halves portfolio

    08 Aug 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/cash-strapped-kiora-sharpens-focus-rare-retinal-diseases-looks-partner-other-assets

    Gabrielle Masson FIERCE BIOTECH
    08 Aug 2023
    Share Share
    Groundbreaking trial underway to improve vision in individuals with RP
    Groundbreaking trial underway to improve vision in individuals with RP

    14 Feb 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/groundbreaking-clinical-trial-underway-to-improve-vision-in-individuals-with-advanced-retinitis-pigmentosa-rp-301746841.html

    PR NEWSWIRE
    14 Feb 2023
    Share Share
    Kiora Pharmaceuticals concludes subject enrolment in PCED therapy trial
    Kiora Pharmaceuticals concludes subject enrolment in PCED therapy trial

    05 Jan 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/kiora-pced-therapy-trial/

    CLINICAL TRIALS ARENA
    05 Jan 2023
    Share Share
    Kiora Pharmaceuticals Announces Publication of Pha1 Trial Results for KIO-100
    Kiora Pharmaceuticals Announces Publication of Pha1 Trial Results for KIO-100

    17 Oct 2022

    // PRESS RELEASE

    https://ir.kiorapharma.com/news-events/press-releases/detail/165/kiora-pharmaceuticals-announces-publication-of-phase-1

    PRESS RELEASE
    17 Oct 2022
    Share Share
    Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
    Kiora Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

    13 Oct 2022

    // PRESS RELEASE

    https://ir.kiorapharma.com/news-events/press-releases/detail/164/kiora-pharmaceuticals-regains-compliance-with-nasdaq

    PRESS RELEASE
    13 Oct 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search